Share
News

Pharmacy Board Retracts Hydroxychloroquine Ban a Day After Issuing It

Share

One day after the Ohio Board of Pharmacy acted to ban the use of the drug hydroxychloroquine to treat COVID-19, the board reversed its decision.

The anti-malarial drug has shown promise as a treatment for individuals infected with the coronavirus, although the jury is still out on its overall effectiveness. Its use has been supported by President Donald Trump, which has led to extensive media pushback criticizing the virus.

The action to allow the drug to be prescribed came as the Ohio Department of Health reported the state had more than 1,100 people hospitalized who have been diagnosed with COVID-19, according to Fox News. The 1,122 people reported hospitalized on Tuesday topped a previous state high of 1,103 in April.

A terse note on the board’s website said that as “a result of the feedback received by the medical and patient community and at the request of Governor DeWine, the State of Ohio Board of Pharmacy has withdrawn proposed rule 4729:5-5-21 of the Administrative Code. Therefore, prohibitions on the prescribing of chloroquine and hydroxychloroquine in Ohio for the treatment of COVID-19 will not take effect at this time.”

“This will allow the Board to reexamine the issue with the assistance of the State Medical Board of Ohio, clinical experts, and other stakeholders to determine appropriate next steps,” the notice said.

Trending:
'Holiday Nightmare Comes True' When Man Makes Strange Discovery in a Ravine on His Property

The rule had been scheduled to take effect Thursday, and the board did not further explain its reasoning for the change.

Gov. Mike DeWine said Thursday he sided with Stephen Hahn, commissioner of the Food and Drug Administration, that decisions on treatments should be made between patients and their doctors, according to the Dayton Daily News.

“Therefore, I am asking the Ohio Board of Pharmacy to halt their new rule prohibiting the selling or dispensing of hydroxychloroquine or chloroquine for the treatment or prevention of COVID-19,” DeWine said.

“The Board of Pharmacy and the State Medical Board of Ohio should revisit the issue, listen to the best medical science, and open the process up for comment and testimony from experts.”


The reversal of the ban on hydroxychloroquine came as the state was revising its coronavirus rules by limiting the hours of bars to deal with a recent spike in cases.

Related:
Military Stepping in as Situation in Michigan Becomes 'Dire'


Cameron McNamee, director of board policy and communications, told the Columbus Dispatch the initial ban on hydroxychloroquine was “a patient safety issue.”

Should the government let patients and doctors make health decisions?

McNamee said Trump’s advocacy concerning the drug was not the reason the board was trying to restrict its use.

“We’re looking at the best science to determine what’s best for the patients of Ohio.”

“The long and short of it is, we want people to focus on what works, such as social distancing and mask use,” McNamee said. “We ultimately want to make sure people are being safe and not exposing themselves to drugs that have shown not to be effective in treating COVID-19.”

Truth and Accuracy

Submit a Correction →



We are committed to truth and accuracy in all of our journalism. Read our editorial standards.

Tags:
, , , ,
Share
Jack Davis is a freelance writer who joined The Western Journal in July 2015 and chronicled the campaign that saw President Donald Trump elected. Since then, he has written extensively for The Western Journal on the Trump administration as well as foreign policy and military issues.
Jack Davis is a freelance writer who joined The Western Journal in July 2015 and chronicled the campaign that saw President Donald Trump elected. Since then, he has written extensively for The Western Journal on the Trump administration as well as foreign policy and military issues.
Jack can be reached at jackwritings1@gmail.com.
Location
New York City
Languages Spoken
English
Topics of Expertise
Politics, Foreign Policy, Military & Defense Issues




Conversation

Notice: Due to threatened de-monetization, we have temporarily removed commenting while we build a long-term commenting solution that allows you to voice your opinion freely and allows us to continue to publish the news fearlessly and cover topics that you care about. If you would like to personally partner with The Western Journal to help us continue publishing while under relentless assault by Big Tech, please visit our subscription page here. We encourage you to share this article and discuss with your friends.